Lundbeck Foundation

The Lundbeck Foundation is a commercial foundation established in 1954 by Grete Lundbeck, widow of the founder of the pharmaceutical company H. Lundbeck A/S. The main objective of the Lundbeck Foundation is to maintain and expand the activities of the Lundbeck Group, and to provide financial support for research of the highest quality in biomedical and natural sciences.

The Lundbeck Foundation is a commercial foundation that aims to significantly improve people’s health and lives by supporting research at the highest level within biomedicin and the natural sciences and with a connection to Denmark.

The Foundation's support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. It grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. Geographically, research in Denmark receives the highest priority, though it may be in connection with international collaborative research projects.

The Lundbeck Foundation with its grant activities:

  • Supports independent research of the highest international quality with special focus on young researchers within neuroscience, psychiatry and allergology/immune modulation.
  • Promotes research internationalization by specifically supporting collaboration between leading Danish and international research groups.
  • Motivates, inspires and recognizes research talent by awarding research prizes and fellowships.

In 2010, the Foundation granted DKK 384 million (approx. € 51,5 million) and expects to grant approx. DKK 400 million (approx. € 53 million) to research in biomedical and natural sciences in 2011.

Cookie Policy
You are now leaving elaiapharm.com